Specifically, we identified CXCL5 as a key chemokine in collagen I-induced NET formation and show that the pharmacologic blockade of DDR1 effectively prevents collagen induction of CXCL5, subsequent NET formation, and cancer cell invasion. This evidence concerns the gene DDR1 and cancer.